Mark Sawicki - Mar 14, 2025 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Scientific Officer
Signature
/s/ Mark Sawicki
Stock symbol
CYRX
Transactions as of
Mar 14, 2025
Transactions value $
-$13,162
Form type
4
Date filed
3/18/2025, 07:06 PM
Previous filing
Mar 11, 2025
Next filing
Mar 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Award $0 +9K +11.46% $0.00 87.5K Mar 14, 2025 Direct F1
transaction CYRX Common Stock Sale -$13.2K -2.09K -2.39% $6.29 85.4K Mar 17, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Award $0 +24K $0.00 24K Mar 14, 2025 Common Stock 24K $7.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.
F2 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F3 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.